📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-07 17:42
136 analysed today
FollowTelegram
136
Today
149,537
All-time analysed
42,893
Positive
6,653
Negative
91,318
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
4 announcements match the current filters (relevance ≥ 5).
Rs 28.53 Cr Q1 Profit: DCMNVL Reports 10x YoY PAT Growth; Revenue Up 13.8%
DCM Nouvelle Limited delivered a massive earnings beat for Q1 FY27, with consolidated net profit surging to Rs 28.53 Cr from just Rs 2.85 Cr in the same quarter last year. Revenue grew 13.8% YoY to Rs 287.43 Cr, driven by strong performance in the textile segment and a 111% sequential growth in the nascent chemicals business. Notably, the quarterly standalone PAT of Rs 31.45 Cr represents nearly 20% of the company's current market capitalization, indicating a significant turnaround in profitability. However, the consolidated profit remains lower than standalone, suggesting the specialty chemicals subsidiary is still incurring losses during its scale-up phase.
Confidence: HIGH
What changedThe company has transitioned from marginal profitability to substantial quarterly earnings, with Q1 FY27 profit exceeding the entire previous year's TTM PAT by over 14 times.
Why it mattersThe sharp increase in profitability and EPS (Rs 16.84 for the quarter) relative to the stock price (Rs 156.9) suggests a potential fundamental re-rating if these operational efficiencies and margins are maintained.
Consolidated PAT (Q1 FY27): Rs 28.53 CrPAT as % of Market Cap: 17.6%Consolidated Revenue (Q1 FY27): Rs 287.43 CrChemicals Segment Revenue: Rs 3.98 CrStandalone EPS (Q1 FY27): Rs 16.84
📅 Short termThe stock is likely to react very positively in the short term due to the massive earnings surprise and the high quarterly EPS relative to the current market price.
📈 Long termThe long-term outlook depends on the successful scaling of the specialty chemicals business to provide higher-margin stability against the cyclical nature of the cotton textile industry.
⚠ Risk flags
- Subsidiary losses (Consolidated profit is lower than Standalone)
- High Debt-to-Equity ratio (1.0)
- Cyclicality of raw cotton prices
Key Highlights
Consolidated Net Profit jumped to Rs 28.53 Cr in Q1 FY27 from Rs 2.85 Cr in Q1 FY26.
Consolidated Revenue from operations increased to Rs 287.43 Cr, up 13.8% YoY.
Chemicals segment revenue grew to Rs 3.98 Cr from Rs 1.88 Cr in the previous quarter.
Standalone EPS for the quarter reached Rs 16.84, compared to Rs 3.57 in the year-ago period.
Textile segment Profit Before Tax (PBT) improved significantly to Rs 42.05 Cr from Rs 8.90 Cr YoY.
👀 What to Watch
Investors should monitor the sustainability of these high textile margins and the pace at which the specialty chemicals subsidiary (DCMNSCL) reaches break-even, as it currently drags down consolidated profits.
DCM Nouvelle Reports FY26 Net Loss of ₹18.02 Cr Impacted by ₹31.47 Cr Exceptional Item
DCM Nouvelle Limited reported a significant swing to a net loss of ₹18.02 crore for the full year ended March 31, 2026, compared to a profit of ₹22.67 crore in the previous fiscal. The bottom line was severely impacted by a one-time exceptional charge of ₹31.47 crore recognized in the fourth quarter. Annual revenue from operations also saw a marginal decline of 4.1%, settling at ₹1,015.17 crore. On a positive note, the company successfully reduced its finance costs by approximately 27.7% YoY, indicating improved debt management.
Key Highlights
Annual revenue from operations decreased to ₹1,015.17 crore from ₹1,058.45 crore in FY25.
Recorded a consolidated net loss of ₹18.02 crore for FY26 against a profit of ₹22.67 crore in FY25.
A major exceptional item of ₹31.47 crore in Q4 FY26 led to a quarterly loss of ₹24.82 crore.
Finance costs for the year were reduced to ₹18.88 crore from ₹26.11 crore in the previous year.
Earnings Per Share (EPS) fell sharply to -₹9.65 from ₹12.14 YoY.
👀 What to Watch
Investors should seek clarity on the nature of the ₹31.47 crore exceptional item to understand if it is a non-recurring event. While the reduction in finance costs is positive, the decline in revenue and the shift to a net loss warrant a cautious approach until operational stability is restored.
DCM Nouvelle Q3 Results: Revenue up 14.5% QoQ, Net Loss of ₹33.9 Cr due to Subsidiary Impairment
DCM Nouvelle reported a revenue of ₹269.21 crore for Q3 FY26, a 14.5% increase sequentially from ₹235.11 crore in Q2. Despite the revenue growth and improved operational profit before tax of ₹4.58 crore, the company posted a net loss of ₹33.90 crore. This loss was primarily driven by a significant non-cash exceptional item of ₹35.61 crore representing an impairment provision for its subsidiary, DCM Nouvelle Specialty Chemicals Limited. Additionally, the company recognized a ₹1.86 crore charge related to the implementation of new labor codes.
Key Highlights
Revenue from operations grew 14.5% QoQ to ₹269.21 crore, though 9M revenue is down 3.8% YoY.
Reported a net loss of ₹33.90 crore in Q3 FY26 against a profit of ₹2.21 crore in Q3 FY25.
Recognized a one-time impairment charge of ₹35.61 crore for its specialty chemicals subsidiary based on value-in-use assessment.
Operational profit before exceptional items improved to ₹4.58 crore from ₹1.88 crore in the preceding quarter.
Exceptional items also include a ₹1.86 crore statutory impact from the notification of new Labour Codes.
👀 What to Watch
Investors should exercise caution as the large impairment suggests the specialty chemicals venture is underperforming expectations. While the core textile business shows signs of sequential recovery, the overall financial health is currently weighed down by subsidiary-level write-downs.
DCMNVL: Rajinder Khanna Re-designated as Independent Director
DCM Nouvelle Limited's board meeting on December 05, 2025, approved the re-designation of Mr. Rajinder Khanna from Additional Non-Executive Non-Independent Director to Additional Non-Executive Independent Director. This change is effective from December 05, 2025, subject to shareholder approval. Mr. Khanna has 46 years of experience in the Government of India. He is not debarred from holding the office of Director by any SEBI order.
Key Highlights
Mr. Rajinder Khanna re-designated as Additional Non-Executive Independent Director effective December 05, 2025
Mr. Khanna has 46 years of experience in the Government of India
Board Meeting commenced at 03:30 P.M. and concluded at 03:50 P.M.
👀 What to Watch
Shareholders should review Mr. Khanna's profile and experience as they consider approving his re-designation at the upcoming shareholder meeting. Monitor company announcements for updates on the shareholder vote.
